Furthermore, CDK12 also lethally interacts with proto-oncogenes such as MYC and EWS/ FLI (Ewing sarcoma (ES) oncoprotein) and these interactions also provide an opportunity for a therapeutic target [59-60]. This evidence concerns the gene MYC and Ewing sarcoma.